Shares of Moderna Inc. fell sharply on Monday after the biotech firm projected a steep decline in 2025 revenues, falling below Wall Street expectations. The company, known for its COVID-19 vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback